CA2317530C - Dysuria remedies - Google Patents

Dysuria remedies Download PDF

Info

Publication number
CA2317530C
CA2317530C CA002317530A CA2317530A CA2317530C CA 2317530 C CA2317530 C CA 2317530C CA 002317530 A CA002317530 A CA 002317530A CA 2317530 A CA2317530 A CA 2317530A CA 2317530 C CA2317530 C CA 2317530C
Authority
CA
Canada
Prior art keywords
cystitis
bladder
disease
therapeutic drug
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002317530A
Other languages
English (en)
French (fr)
Other versions
CA2317530A1 (en
Inventor
Tamio Yamauchi
Tomohiro Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CA2317530A1 publication Critical patent/CA2317530A1/en
Application granted granted Critical
Publication of CA2317530C publication Critical patent/CA2317530C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002317530A 1998-11-05 1999-11-05 Dysuria remedies Expired - Fee Related CA2317530C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP31436998 1998-11-05
JP10/314369 1998-11-05
JP3977999 1999-02-18
JP11/39779 1999-02-18
PCT/JP1999/006170 WO2000027383A1 (fr) 1998-11-05 1999-11-05 Medicaments contre la dysurie

Publications (2)

Publication Number Publication Date
CA2317530A1 CA2317530A1 (en) 2000-05-18
CA2317530C true CA2317530C (en) 2004-04-27

Family

ID=26379168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002317530A Expired - Fee Related CA2317530C (en) 1998-11-05 1999-11-05 Dysuria remedies

Country Status (10)

Country Link
US (1) US6329428B1 (ko)
EP (1) EP1055426B1 (ko)
JP (1) JP3507439B2 (ko)
KR (1) KR100375003B1 (ko)
CN (1) CN1224384C (ko)
AT (1) ATE413869T1 (ko)
AU (1) AU734793B2 (ko)
CA (1) CA2317530C (ko)
DE (1) DE69939894D1 (ko)
WO (1) WO2000027383A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4015954B2 (ja) * 2001-04-16 2007-11-28 大鵬薬品工業株式会社 トシル酸スプラタスト結晶
EP1405638B1 (en) * 2001-07-10 2011-02-09 Astellas Pharma Inc. Pharmaceutical composition comprising quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinoline-2-carboxylate for treatment of interstitial cystitis and/or abacterial prostatitis
JP3921664B2 (ja) * 2002-10-29 2007-05-30 大鵬薬品工業株式会社 非細菌性前立腺炎モデル動物
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
KR20080016735A (ko) * 2005-06-27 2008-02-21 각코우호우진 쥰텐도 헤르페스 바이러스 유래 동통 치료제
AU2007339153B2 (en) * 2006-12-26 2010-11-25 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for diabetic neuropathy
US20100029590A1 (en) * 2007-02-14 2010-02-04 Prelief Inc. Methods for treating or preventing hemorrhagic cystitis using a glycerophosphate salt
US7902260B2 (en) * 2007-02-28 2011-03-08 Kemphys Ltd. Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
US20080275015A1 (en) * 2007-05-01 2008-11-06 Potter Jeffrey A Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
WO2011065444A1 (ja) 2009-11-27 2011-06-03 学校法人東海大学 抗血栓剤
JP2022013721A (ja) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤
JP6894555B1 (ja) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 排尿症状治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
GB2274241B (en) * 1993-01-19 1996-06-05 Rack Eng Improvements relating to pull-out shelf support systems
TW264385B (ko) 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO1996033741A1 (fr) * 1995-04-24 1996-10-31 Taiho Pharmaceutical Co., Ltd. Remede pour maladies allergiques, a appliquer dans la region du nez

Also Published As

Publication number Publication date
KR20010033852A (ko) 2001-04-25
DE69939894D1 (de) 2008-12-24
AU734793B2 (en) 2001-06-21
ATE413869T1 (de) 2008-11-15
CN1224384C (zh) 2005-10-26
JP3507439B2 (ja) 2004-03-15
US6329428B1 (en) 2001-12-11
CN1287485A (zh) 2001-03-14
WO2000027383A1 (fr) 2000-05-18
EP1055426B1 (en) 2008-11-12
CA2317530A1 (en) 2000-05-18
EP1055426A4 (en) 2005-04-06
EP1055426A1 (en) 2000-11-29
AU1077900A (en) 2000-05-29
KR100375003B1 (ko) 2003-03-06

Similar Documents

Publication Publication Date Title
CA2317530C (en) Dysuria remedies
JP4354528B2 (ja) 間質性膀胱炎の治療へのヒアルロン酸の使用
WO2005072751A1 (en) Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
JP2001509480A (ja) 男性勃起機能不全を治療するための改良された方法及び組成物
Kanotra et al. Pseudocyst of pinna: a recurrence-free approach
AU699872B2 (en) Use of debromohymenialdisine and related compounds for treating osteoarthritis
Teixeira et al. The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits
US6232301B1 (en) Remedies for bladder disorders
EP0651637B1 (en) Control of wound scar production with calmodulin inhibitors or protein kinase c inhibitors
RU2527679C2 (ru) Терапевтическое средство для лечения заболевания нижних мочевых путей и средство для улучшения симптома нижних мочевых путей
Pruet et al. Management of the airway in patients with angioedema
JP5342695B2 (ja) ヒドロキシクロロキンを含有する痔核治療のための局所投与用注射剤組成物
KR20010083123A (ko) 알레르기 질환 치료제
US4446149A (en) Medicine for treatment of cervical erosion
US6548487B2 (en) Agent for treatment of bladder troubles
US20060128738A1 (en) Treatment of interstitial cystitis using cannabinoid analogs
US11944650B2 (en) Method of treating or preventing hernia formation
US8283323B2 (en) Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development
US20080194471A1 (en) Compositions and Methods for Treating Wounds
Thomas et al. Results obtained in treating genito-urinary tuberculosis with streptomycin
Upadhyay et al. A case study illustrating the use of an integrated approach to treat secondary Anal Fistula Post I&D of Perianal Abscess
Meena et al. A CASE STUDY OF PARTIAL FISTULECTOMY WITH KSHARSUTRA LIGATION IN TRANSSPHINCTERIC FISTULA IN ANO
Yadav et al. A SINGLE CASE STUDY OF 21 COATED APAMARGA KSHARASUTRA IN THE MANAGEMENT OF BHAGANDARA (FISTULA IN ANO)
Mizuno et al. Pre-and postoperative therapy in cataract extraction
Donnelly Carcinoma of the Prostate: Screening and investigative techniques and treatments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161107